https://www.bloomberg.com/authors/ABoerJhBe84/marthe-fourcadehttps://www.bloomberg.com/feeds/static/images/bloomberg_logo_black.pnghttps://www.bloomberg.com/authors/ABoerJhBe84/marthe-fourcadeRSS for NodeWed, 27 Aug 2025 19:28:13 GMThttps://www.bloomberg.com/news/articles/2025-08-18/bayer-reaches-settlement-over-seattle-area-school-pcb-caseshttps://www.bloomberg.com/news/articles/2025-08-18/bayer-reaches-settlement-over-seattle-area-school-pcb-casesMon, 18 Aug 2025 12:41:50 GMTA machine secures lids onto bottles of Roundup weed killer on the production line at the herbicide manufacturing facility.https://www.bloomberg.com/news/articles/2025-08-18/soho-house-agrees-to-be-taken-private-in-2-7-billion-deal-meh01nedhttps://www.bloomberg.com/news/articles/2025-08-18/soho-house-agrees-to-be-taken-private-in-2-7-billion-deal-meh01nedMon, 18 Aug 2025 10:42:01 GMThttps://www.bloomberg.com/news/articles/2025-07-28/nordic-permira-to-take-bavarian-private-for-3-billionhttps://www.bloomberg.com/news/articles/2025-07-28/nordic-permira-to-take-bavarian-private-for-3-billionMon, 28 Jul 2025 06:28:18 GMThttps://www.bloomberg.com/news/articles/2025-05-22/honeywell-to-buy-johnson-matthey-s-catalyst-business-for-2-4-billionhttps://www.bloomberg.com/news/articles/2025-05-22/honeywell-to-buy-johnson-matthey-s-catalyst-business-for-2-4-billionThu, 22 May 2025 06:23:58 GMThttps://www.bloomberg.com/news/articles/2025-04-22/novo-nordisk-slides-on-pressure-from-lilly-s-pill-studyhttps://www.bloomberg.com/news/articles/2025-04-22/novo-nordisk-slides-on-pressure-from-lilly-s-pill-studyTue, 22 Apr 2025 07:07:55 GMThttps://www.bloomberg.com/news/articles/2025-02-20/indivior-plunges-as-drugmaker-warns-of-falling-revenue-profithttps://www.bloomberg.com/news/articles/2025-02-20/indivior-plunges-as-drugmaker-warns-of-falling-revenue-profitThu, 20 Feb 2025 08:47:59 GMTA box of Indivior's Suboxone medication sits on a pharmacy shelf in Provo, Utah, U.S., on Wednesday, Aug. 31, 2016. A Nov. 2015 forecast from health data firm IMS Health expects global sales of brand and generic prescription drugs, and nonprescription medicines, to total $1.4 trillion in 2020.https://www.bloomberg.com/news/articles/2024-12-30/novartis-says-drug-helps-children-with-spinal-atrophy-in-studyhttps://www.bloomberg.com/news/articles/2024-12-30/novartis-says-drug-helps-children-with-spinal-atrophy-in-studyMon, 30 Dec 2024 09:18:02 GMThttps://www.bloomberg.com/news/articles/2024-12-23/astra-s-tagrisso-gets-eu-nod-for-another-form-of-lung-cancerhttps://www.bloomberg.com/news/articles/2024-12-23/astra-s-tagrisso-gets-eu-nod-for-another-form-of-lung-cancerMon, 23 Dec 2024 07:52:28 GMTTagrissohttps://www.bloomberg.com/news/articles/2024-06-10/ipsen-genfit-medicine-cleared-by-fda-for-rare-liver-disorderhttps://www.bloomberg.com/news/articles/2024-06-10/ipsen-genfit-medicine-cleared-by-fda-for-rare-liver-disorderMon, 10 Jun 2024 21:24:53 GMThttps://www.bloomberg.com/news/articles/2024-05-27/astra-daiichi-drug-extends-lives-of-some-lung-cancer-patientshttps://www.bloomberg.com/news/articles/2024-05-27/astra-daiichi-drug-extends-lives-of-some-lung-cancer-patientsMon, 27 May 2024 08:04:06 GMThttps://www.bloomberg.com/news/articles/2024-05-21/roche-breast-cancer-medicine-to-get-expedited-fda-reviewhttps://www.bloomberg.com/news/articles/2024-05-21/roche-breast-cancer-medicine-to-get-expedited-fda-reviewTue, 21 May 2024 10:37:29 GMThttps://www.bloomberg.com/news/articles/2024-03-18/intermittent-fasting-linked-to-heart-risks-in-research-surprisehttps://www.bloomberg.com/news/articles/2024-03-18/intermittent-fasting-linked-to-heart-risks-in-research-surpriseMon, 18 Mar 2024 20:00:00 GMThttps://www.bloomberg.com/news/articles/2024-02-29/gsk-settles-another-zantac-cancer-lawsuit-in-californiahttps://www.bloomberg.com/news/articles/2024-02-29/gsk-settles-another-zantac-cancer-lawsuit-in-californiaThu, 29 Feb 2024 07:33:06 GMTZantac pills.https://www.bloomberg.com/news/articles/2024-02-12/novo-holder-boosts-investments-with-7-billion-goal-ft-reportshttps://www.bloomberg.com/news/articles/2024-02-12/novo-holder-boosts-investments-with-7-billion-goal-ft-reportsMon, 12 Feb 2024 08:13:25 GMTNovo Holdings offices in Hellerup, Denmark.https://www.bloomberg.com/news/articles/2024-01-25/haleon-to-sell-chapstick-to-suave-brands-for-430-millionhttps://www.bloomberg.com/news/articles/2024-01-25/haleon-to-sell-chapstick-to-suave-brands-for-430-millionThu, 25 Jan 2024 07:41:51 GMTChapStick lip balm products.https://www.bloomberg.com/news/articles/2024-01-09/gsk-to-buy-asthma-drug-developer-aiolos-for-up-to-1-4-billionhttps://www.bloomberg.com/news/articles/2024-01-09/gsk-to-buy-asthma-drug-developer-aiolos-for-up-to-1-4-billionTue, 09 Jan 2024 07:23:15 GMThttps://www.bloomberg.com/news/articles/2023-12-18/gsk-says-cancer-medicine-cleared-by-eu-meets-another-study-goalhttps://www.bloomberg.com/news/articles/2023-12-18/gsk-says-cancer-medicine-cleared-by-eu-meets-another-study-goalMon, 18 Dec 2023 07:28:46 GMThttps://www.bloomberg.com/news/articles/2023-12-12/astrazeneca-to-pay-up-to-1-1-billion-for-us-vaccine-developerhttps://www.bloomberg.com/news/articles/2023-12-12/astrazeneca-to-pay-up-to-1-1-billion-for-us-vaccine-developerTue, 12 Dec 2023 07:35:09 GMTAstraZeneca branding. Photographer: Jason Aldenhttps://www.bloomberg.com/news/articles/2023-12-11/gsk-immune-drug-cleared-by-eu-for-endometrial-cancerhttps://www.bloomberg.com/news/articles/2023-12-11/gsk-immune-drug-cleared-by-eu-for-endometrial-cancerMon, 11 Dec 2023 07:44:59 GMThttps://www.bloomberg.com/news/newsletters/2023-12-08/can-ozempic-wegovy-treat-alcoholismhttps://www.bloomberg.com/news/newsletters/2023-12-08/can-ozempic-wegovy-treat-alcoholismFri, 08 Dec 2023 11:00:11 GMTAn injection pen at the Novo production facilities in Hillerod. Novo says that alcohol-use disorder isn’t one of its focus areas.